Cargando…

Triglycerides and Cardiovascular Risk

In 1996 a meta-analysis was published showing that an increase in plasma triglyceride (TG) levels was associated with an increase in CHD risk, even after adjustment for high density lipoprotein cholesterol (HDL-C) levels. Very recently, two studies were published that further extent the early observ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harchaoui, K.E.L, Visser, M.E, Kastelein, J.J.P, Stroes, E.S, Dallinga-Thie, G.M
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd. 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822144/ https://www.ncbi.nlm.nih.gov/pubmed/20676280 http://dx.doi.org/10.2174/157340309788970315

Ejemplares similares

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
por: Dallinga-Thie, Geesje M., et al.
Publicado: (2016)

Genome-Wide Association Studies in Atherosclerosis
por: Sivapalaratnam, S., et al.
Publicado: (2011)

Loss of Function in Heparan Sulfate Elongation Genes EXT1 and EXT 2 Results in Improved Nitric Oxide Bioavailability and Endothelial Function
por: Mooij, H. L., et al.
Publicado: (2014)

Lipid Measures and Cardiovascular Disease Prediction
por: van Wijk, Diederik F., et al.
Publicado: (2009)

Thyroid Hormone Mimetics: the Past, Current Status and Future Challenges
por: Elbers, L.P.B., et al.
Publicado: (2016)

In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL
por: Franssen, Remco, et al.
Publicado: (2012)

Inflammatory Effects of Triglycerides: Relevant or Redundant?
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023)

Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient-derived circulating monocytes using confocal microscopy
por: Schnitzler, Johan G., et al.
Publicado: (2017)

Working towards full eradication of lipid-driven cardiovascular risk?
por: Nurmohamed, N. S., et al.
Publicado: (2021)

Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
por: Scherer, Daniel J, et al.
Publicado: (2015)

Triglyceride and cardiovascular risk: A critical appraisal
por: Singh, Awadhesh Kumar, et al.
Publicado: (2016)

The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro
por: Dallinga, Marchien G., et al.
Publicado: (2021)

Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes
por: Wang, Yutang, et al.
Publicado: (2022)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice
por: Udayappan, Shanthadevi, et al.
Publicado: (2016)

Different inflammatory pathways underlying cardiovascular risk in secondary prevention( )
por: Nurmohamed, Nick S, et al.
Publicado: (2022)

Carriers of Loss-of-Function Mutations in EXT Display Impaired Pancreatic Beta-Cell Reserve Due to Smaller Pancreas Volume
por: Bernelot Moens, Sophie J., et al.
Publicado: (2014)

HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk
por: Girona, Josefa, et al.
Publicado: (2019)

Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study
por: Lindman, Anja S., et al.
Publicado: (2010)

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis
por: Wijbrandts, C A, et al.
Publicado: (2008)

Causality of small and large intestinal microbiota in weight regulation and insulin resistance
por: Scheithauer, Torsten P.M., et al.
Publicado: (2016)

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial
por: Visser, Maartje E., et al.
Publicado: (2012)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Triglyceride glucose index: A new biomarker in predicting cardiovascular risk
por: Araújo, Susilane Pereira, et al.
Publicado: (2022)

Triglyceride Level and Cardiovascular Risk Reduction Using Pemafibrate Compared with Fibrates
por: Masuda, Daisaku
Publicado: (2023)

Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis
por: Moriarty, Patrick M., et al.
Publicado: (2020)

Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations
por: van den Boogert, Marjolein A.W., et al.
Publicado: (2019)

The challenge of choosing in cardiovascular risk management
por: Hoogeveen, R. M., et al.
Publicado: (2021)

Genetic risk score and adiposity interact to influence triglyceride levels in a cohort of Filipino women
por: Zubair, N, et al.
Publicado: (2014)

Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome
por: Smits, Loek P., et al.
Publicado: (2018)

Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk
por: Cai, Xiao-ling, et al.
Publicado: (2023)

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
por: Kosmas, Constantine E., et al.
Publicado: (2023)

Effects of imatinib on vascular insulin sensitivity and free fatty acid transport in early weight gain
por: Box, Camiel V. J., et al.
Publicado: (2021)

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
por: Brinton, Eliot A, et al.
Publicado: (2013)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
por: Toth, Peter P
Publicado: (2016)

Association between triglyceride levels and cardiovascular disease in patients with acute pancreatitis
por: Copeland, Laurel A., et al.
Publicado: (2018)

Triglycerides and Residual Atherosclerotic Risk
por: Raposeiras-Roubin, Sergio, et al.
Publicado: (2021)

Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data
por: Che, Bizhong, et al.
Publicado: (2023)

The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease
por: Gabani, Mohanad, et al.
Publicado: (2023)

Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder
por: Li, Ming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tifejkltt0qo3b12kcda8po4re